Shandong Wohua Pharmaceutical Co., Ltd. (SHE:002107)
China flag China · Delayed Price · Currency is CNY
7.26
+0.01 (0.14%)
Feb 4, 2026, 3:04 PM CST

SHE:002107 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
812.08758.76905.11,013941.8
Other Revenue
4.875.044.41.890.88
816.95763.79909.511,015942.67
Revenue Growth (YoY)
6.96%-16.02%-10.38%7.65%-6.30%
Cost of Revenue
203.07210.83234.75255.27214.94
Gross Profit
613.89552.97674.76759.55727.74
Selling, General & Admin
473.38463.38569.12588.31473.06
Research & Development
36.3940.6545.3550.1147.48
Other Operating Expenses
14.3512.915.1917.616.14
Operating Expenses
524.46515.9627.71657.74535.77
Operating Income
89.4337.0647.05101.81191.97
Interest Expense
-0.06-0.02-0.04-0.03-4.7
Interest & Investment Income
5.814.935.234.676.79
Other Non Operating Income (Expenses)
3.41-2.94-0.82-1.65-1.16
EBT Excluding Unusual Items
98.5839.0451.43104.81192.91
Impairment of Goodwill
-----13.54
Gain (Loss) on Sale of Assets
---2.15-
Asset Writedown
-0.17-0.03-0.06-0.44-0.02
Legal Settlements
-1.29-0.13-0.14-0.26-0.53
Other Unusual Items
5.263.773.414.5411.13
Pretax Income
102.3842.6554.64110.79189.96
Income Tax Expense
13.598.898.0120.9128.63
Earnings From Continuing Operations
88.7933.7646.6389.89161.32
Minority Interest in Earnings
6.922.6412.1417.52.07
Net Income
95.7236.458.77107.39163.39
Net Income to Common
95.7236.458.77107.39163.39
Net Income Growth
162.93%-38.05%-45.27%-34.28%-8.66%
Shares Outstanding (Basic)
563607588565584
Shares Outstanding (Diluted)
563607588565584
Shares Change (YoY)
-7.20%3.24%3.98%-3.15%1.13%
EPS (Basic)
0.170.060.100.190.28
EPS (Diluted)
0.170.060.100.190.28
EPS Growth
183.33%-40.00%-47.37%-32.14%-9.68%
Free Cash Flow
127.6687.69126.53178.49181.04
Free Cash Flow Per Share
0.230.140.210.320.31
Dividend Per Share
0.266-0.250-0.260
Gross Margin
75.14%72.40%74.19%74.85%77.20%
Operating Margin
10.95%4.85%5.17%10.03%20.36%
Profit Margin
11.72%4.77%6.46%10.58%17.33%
Free Cash Flow Margin
15.63%11.48%13.91%17.59%19.20%
EBITDA
1206979.57136.79225.02
EBITDA Margin
14.69%9.03%8.75%13.48%23.87%
D&A For EBITDA
30.5731.9332.5234.9933.05
EBIT
89.4337.0647.05101.81191.97
EBIT Margin
10.95%4.85%5.17%10.03%20.36%
Effective Tax Rate
13.27%20.84%14.66%18.87%15.07%
Revenue as Reported
816.95763.79909.511,015942.67
Source: S&P Global Market Intelligence. Standard template. Financial Sources.